Previous 10 | Next 10 |
2024-02-20 10:28:47 ET More on Sanofi Sanofi (SNY) Q4 2023 Earnings Call Transcript Sanofi 2023 Q4 - Results - Earnings Call Presentation Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Denali slips as Sanofi fails in mid-stage trial fo...
2024-02-16 10:05:39 ET More on Denali, Sanofi, etc. Sanofi (SNY) Q4 2023 Earnings Call Transcript Sanofi 2023 Q4 - Results - Earnings Call Presentation Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Sanofi, Regeneron win Japan approval...
2024-02-16 07:15:00 ET Equity markets can be highly volatile in the short run. Where the S&P 500 might land in the next six months is anyone's guess. However, over a decade, major indexes tend to move steadily in the right direction and deliver competitive returns. That makes invest...
2024-02-16 06:17:43 ET Sanofi ( NASDAQ: SNY ) and Regeneron Pharmaceuticals ( NASDAQ: REGN ) announced Friday marketing and manufacturing authorization for their blockbuster anti-inflammatory medication, Dupixent, in Japan for the treatment of chronic spontaneous urticar...
2024-02-15 08:23:45 ET Summary Positive results achieved in phase 1/2 MGT009 study using bota-vec for the treatment of patients with XLRP; Patients given this gene therapy achieved meaningful improvement of vision. Enrollment completed in ongoing phase 3 LUMEOS study, using b...
2024-02-15 02:45:38 ET Summary GSK plc is a multinational “big pharma” and long-time leader in the vaccine, HIV, and respiratory disease areas. Shingrix and RSV vaccine sales in 2023 exceeded expectations and appear to show no sign of slowing down. GSK’s f...
2024-02-12 15:09:25 ET Summary IGM Biosciences, Inc. is conducting phase 1b studies for imvotamab in patients with severe systemic lupus erythematosus and rheumatoid arthritis, with initial results expected in the second half of 2024. The global lupus market is projected to grow t...
2024-02-09 02:51:35 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2024-02-08 15:03:15 ET More on S&P 500 Index: Wholesales Sales December 2023: Economy Too Hot For Fed Cuts It Makes (No) Sense To Be Patient On Rate Cuts Yen Tumbles To New Low On BOJ Comments Nasdaq, Dow mixed as PayPal slide offsets Disney surge; S&...
2024-02-08 07:09:07 ET More on AstraZeneca AstraZeneca's Q4 Earnings: Recognizing The Underrated Gem's Growth Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition AstraZeneca beats t...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...